Agonist substitution-a treatment alternative for high-dose benzodiazepine-dependent patients?

Addiction

Volumn 105, Issue 11, 2010, Pages 1870-1874

  Liebrenz, Michael ^a   Boesch, Lukas ^a   Stohler, Rudolf ^a   Caflisch, Carlo ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Agonist treatment; High dose benzodiazepine dependence; Maintenance treatment; Substitution treatment

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; PRESCRIPTION DRUG;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DRUG SUBSTITUTION; DRUG TOLERANCE; HUMAN; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; COGNITION DISORDERS; DRUG SUBSTITUTION; DRUG TOLERANCE; HUMANS; MIDDLE AGED; PRESCRIPTION DRUGS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 78649584339     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.02933.x     Document Type: Article

References (42)

1. Miller N. S., Gold M. S. Benzodiazepines: reconsidered. Adv Alcohol Subst Abuse 1990; 8: 67-84.
2. Sternbach L. H. The benzodiazepine story. J Med Chem 1979; 22: 1-7.
3. Lader M. History of benzodiazepine dependence. J Subst Abuse Treat 1991; 8: 53-9.
4. Lader M. Long-term anxiolytic therapy: the issue of drug withdrawal. J Clin Psychiatry 1987; 48 (Suppl): 12-6.
5. Heberlein A., Bleich S., Kornhuber J., Hillemacher T. [Benzodiazepine dependence: causalities and treatment options]. Fortschr Neurol Psychiatr 2009; 77: 7-15.
6. O'Brien C. P. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005; 66 (Suppl 2): 28-33.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, 4th edn. Washington, DC: American Psychiatric Publishing; 2000.
8. Fang S. Y., Chen C. Y., Chang I. S., Wu E. C., Chang C. M., Lin K. M. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug Alcohol Depend 2009; 104: 140-6.
9. Petitjean S., Ladewig D.,Meier C. R., Amrein R.,Wiesbeck G. A. Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. Int Clin Psychopharmacol 2007; 22: 292-8.
10. Soyka M., Queri S., Kufner H., Rosner S. [Where are the 1.9 million patients dependent on legal drugs hiding?]. Nervenarzt 2005; 76: 72-7.
11. Kan C. C., Hilberink S. R., Breteler M. H. Determination of the main risk factors for benzodiazepine dependence using a multivariate and multidimensional approach. Compr Psychiatry 2004; 45: 88-94.
12. Iguchi M. Y., Handelsman L., Bickel W. K., Griffiths R. R. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 1993; 32: 257- 66.
13. Parr J. M., Kavanagh D. J., Cahill L., Mitchell G., Mc D. Y. R. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction 2009; 104: 13-24.
14. Denis C., Fatseas M., Lavie E., Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev 2006; 3: CD005194.
15. Voshaar R. C., Couvee J. E., van Balkom A. J., Mulder P. G., Zitman F. G. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 2006; 189: 213-20.
16. Lader M., Tylee A., Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs 2009; 23: 19-34.
17. Vorma H., Naukkarinen H., Sarna S., Kuoppasalmi K. Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches. Addiction 2002; 97: 851-9.
18. Lader M. Coming off tranquillizers: a Sisyphean toil. Addiction 2009; 104: 25-6.
19. Voshaar R. C., Gorgels W. J., Mol A. J., van Balkom A. J., Mulder J., van de Lisdonk E. H. et al. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program. Can J Psychiatry 2006; 51: 445-52.
20. Newman R. G. Studying methadone's appropriateness: enough already! Soz Praventivmed 2003; 48 (Suppl. 1): S23-4, discussion S25-7.
21. Ward J., Hall W., Mattick R. P. Role of maintenance treatment in opioid dependence. Lancet 1999; 353: 221- 6.
22. Gordon M. S., Kinlock T.W., Schwartz R. P., O'Grady K. E. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction 2008; 103: 1333-42.
23. Berridge V Heroin prescription and history. N Engl J Med 2009; 361: 820-1.
24. Newman R. G. A success story-waiting to be retold: methadone treatment in New York City. Bull NY Acad Med 1993; 70: 135-45.
25. Dole V. P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA 1965; 193: 646-50.
26. Poisnel G., Dhilly M., Le Boisselier R., Barre L., Debruyne D. Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulation. J Pharmacol Sci 2009; 110: 36-46.
27. Forrester M. B. Flunitrazepam abuse and malicious use in Texas, 1998-2003. Subst Use Misuse 2006; 41: 297-306.
28. Wickes W., Darke S., Ross J. Clobazam maintenance among methadone maintenance patients with problematic benzodiazepine use: five case studies. Drug Alcohol Review 2000; 19: 5.
29. Klein E. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam. J Clin Psychiatry 2002; 63 (Suppl. 14): 27-33.
30. Albeck J. H. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam. J Clin Psychiatry 1987; 48 (Suppl.): 43-9.
31. Weizman T., Gelkopf M., Melamed Y., Adelson M., Bleich A. Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity. Aust NZ J Psychiatry 2003; 37: 458-63.
32. Lingford-Hughes A. R., Welch S., Nutt D. J. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2004; 18: 293-335.
33. Stevens J. C., Pollack M. H. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry 2005; 66 (Suppl. 2): 21-7.
34. Druid H., Holmgren P., Ahlner J. Flunitrazepam: an evaluation of use, abuse and toxicity. Forensic Sci Int 2001; 122: 136-41.
35. Daderman A. M., Fredriksson B., KristianssonM., Nilsson L. H., Lidberg L. Violent behavior, impulsive decision-making, and anterograde amnesia while intoxicated with flunitrazepam and alcohol or other drugs: a case study in forensic psychiatric patients. J Am Acad Psychiatry Law 2002; 30: 238-51.
36. Hollister L. E., Conley F. K., Britt R. H., Shuer L. Long-term use of diazepam. JAMA 1981; 246: 1568-70.
37. Nagy L. M., Krystal J. H., Charney D. S., Merikangas K. R., Woods S. W. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study. J Clin Psychopharmacol 1993; 13: 16-24.
38. Worthington J. J. 3rd, Pollack M. H., Otto M.W., McLean R. Y., Moroz G., Rosenbaum J. F. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull 1998; 34: 199-205.
39. Barker M. J., Greenwood K. M., Jackson M., Crowe S. F. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: ameta-analysis. Arch Clin Neuropsychol 2004; 19: 437-54.
40. Stewart S. A. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005; 66 (Suppl. 2): 9-13.
41. Golombok S., Moodley P., Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988; 18: 365-74.
42. Buffett-Jerrott S. E., Stewart S. H. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 2002; 8: 45-58.